Clinical Performance of Verofilcon A Toric Contact Lenses
1 other identifier
interventional
32
1 country
1
Brief Summary
The goal of this clinical trial is to \[primary purpose: is to determine if Total30 Multi focal toric conntact lensesare comfortable and the willigness for those who have previously worn reusable toric contact lenses are willing to stay in Total30 MFT after 1 month of wear during the duration of the study. Healthy previous reusable toric contact lens weareres will be refit into total30 MFT contact lenses and will be asked to gauge their comfort while wearing the lenses. Healthy adult participants who are presybyopic between the ages of 18-40 can participant, sex and gender are not disqualifiers unless the participant is pregnant or breast feeding. The main question\[s\] it aims to answer \[is/are\] \[primary hypothesis or outcome measure 1Proportions of toric CL wearers who have positive visual acuity scores in comfort and vision after one month of wear. \[primary hypothesis or outcome measure 2\]? Contact lens dry eye-8 scores will be less than 12 indicating high levels of comfort after one month of wear.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Apr 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2026
CompletedFirst Submitted
Initial submission to the registry
May 7, 2026
CompletedFirst Posted
Study publicly available on registry
May 14, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
September 1, 2026
May 14, 2026
May 1, 2026
4 months
May 7, 2026
May 7, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Visual acuity scores
This will be a prospective study to understand if reusable silicone hydrogel toric CL wearers who are presbyopic can be successfully refit into Total30 MFT CLs VAS scores will be judged from -50 to positive 50 with positive numbers being more comfortable and 0 being neutral.
1 month
Secondary Outcomes (2)
Contact lens dry eye 8 questionnaire scores
1 month
Comfort VAS
Day 1, Day 14 and day 29 text messages
Study Arms (1)
TOTAL30 Multifocal Toric contact lenses
EXPERIMENTALThis will be a prospective study to understand if reusable silicone hydrogel toric CL wearers who are presbyopic can be successfully refit into Total30 MFT CLs
Interventions
Participants will be refit into total 30 contact lenses
Eligibility Criteria
You may qualify if:
- Adults, ≥40-year-old, CL wearers with best-corrected 20/20 distance visual acuity or better.
- Requiring +0.75 ADD or more at standard near distance of 40 cm.
- Participants will be required to have worn reusable silicone hydrogel toric CLs in the past year and still at a minimum wearing the CLs occasionally without having significant discomfort or dryness.
- All participants will be required to have a CLDEQ-8 score \<12.
- Participants will be required to be able to wear Total 30MFT CLs (presbyopic plus astigmatism both ≥0.75D OD and OS).
- Astigmatism ranging from 0.75 D to 2.50 D in each eye.
- Participants will be required to wear the study CLs for ≥13 hours each day with no overnight wear.
- Willing to wear study CLs for ≥16 hours on the Day 1 (1st full day), Day 14, and Day 29 when responses will be collected via text message.
- Participants will be willing to wear the CL every day of the week.
- Participants will be required to provide a glasses prescription that is less than 3 years old.
- Visual acuity with habitual reusable silicone hydrogel toric CLs is 20/25 or better in each eye.
You may not qualify if:
- Have worn Total30 MFT in the past
- Are past rigid CL wearers
- Are currently wearing monovision CLs
- Have a history of being diagnosed with dry eye or ocular allergies
- Have known systemic health conditions that are thought to alter tear film physiology
- Have a history of viral eye disease
- Have a history of ocular surgery
- Have a history of severe ocular trauma
- Have a history of corneal dystrophies or degenerations
- Have active ocular infection or inflammation
- Are currently using isotretinoin-derivatives or ocular medications
- Are pregnant or breast feeding
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The Southern College of Optometry
Memphis, Tennessee, 38104, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 7, 2026
First Posted
May 14, 2026
Study Start
April 1, 2026
Primary Completion (Estimated)
August 1, 2026
Study Completion (Estimated)
September 1, 2026
Last Updated
May 14, 2026
Record last verified: 2026-05